WALTHAM, Mass. – August 17, 2012 – PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, announced that its electronic laboratory notebook (ELN) can now be seamlessly integrated with Elsevier’s Reaxys®, a web-based workflow solution designed for chemistry researchers in drug discovery, chemicals and academic research.
“As chemists are increasingly turning to electronic laboratory notebooks to plan, execute and record their experiments, they also need ready access to complementary tools and data sources directly within the ELN interface.” said Michael Stapleton, general manager, PerkinElmer Informatics, “The interoperability of our ELN and Elsevier’s Reaxys provides researchers with access to extensive information on chemical compounds and related physical and pharmacological properties so that they can make better decisions. This integration also allows researchers to save valuable time by providing the ability to rapidly search and import external data while eliminating transcription errors.”
Capturing Reaxys content through PerkinElmer’s ELN gives researchers the power to simultaneously leverage information from both sources in order to make critical decisions throughout the chemistry research workflow. Chemical searches in Reaxys can be initiated in an experimental section in the ELN, based on existing or newly drawn compounds or reactions, and results are immediately available. Once suitable reactions are located and selected in Reaxys, they can be exported directly to the ELN and inserted into a pre-designed experiment, complete with reaction scheme, stoichiometry table and preparation text.
PerkinElmer and Elsevier will host an informative workshop at the American Chemical Society in Philadelphia, PA on August 20th at 8:30 am EST to demonstrate and discuss the benefits of integrating Reaxys and PerkinElmer’s ELN. To register for the workshop, signup here.
Integrating the ELN with Reaxys is available at no extra charge to customers who already have both systems.
PerkinElmer is a leading provider of discovery, collaboration, and knowledge enterprise solutions, desktop software, scientific databases and consulting services to the pharmaceutical, biotechnology, and chemical industries. The Company offers enterprise solutions, desktop software, scientific databases, and professional services for biotechnology, drug discovery and chemical research, including software, databases, and web sites which enable customers to create, analyze and communicate chemical, biological, and scientific information more effectively. Learn about our informatics solutions at www.perkinelmer.com/informatics.
Reaxys® and the Reaxys® trademark are owned and protected by Reed Elsevier Properties SA. All rights reserved.
About PerkinElmer, Inc.
PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. The company reported revenue of approximately $1.9 billion in 2011, has about 7,000 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.
# # #
Corporate Public Relations Specialist